Home Applications 076017 Application 076017
Type ANDA
Sponsor IVAX SUB TEVA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 GABAPENTIN GABAPENTIN TABLET;ORAL 100MG No No 002 GABAPENTIN GABAPENTIN TABLET;ORAL 300MG No No 003 GABAPENTIN GABAPENTIN TABLET;ORAL 400MG No No 004 GABAPENTIN GABAPENTIN TABLET;ORAL 600MG No No 005 GABAPENTIN GABAPENTIN TABLET;ORAL 800MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076017-001 GABAPENTIN GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 A076017-002 GABAPENTIN GABAPENTIN 300MG TABLET / ORAL 2004-04-28 A076017-003 GABAPENTIN GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 A076017-004 GABAPENTIN GABAPENTIN 600MG TABLET / ORAL 2005-04-29 A076017-005 GABAPENTIN GABAPENTIN 800MG TABLET / ORAL 2005-04-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 215 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076017-002 GABAPENTIN 300MG TABLET / ORAL 2004-04-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076017-002 GABAPENTIN 300MG TABLET / ORAL 2004-04-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076017-002 GABAPENTIN 300MG TABLET / ORAL 2004-04-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076017-002 GABAPENTIN 300MG TABLET / ORAL 2004-04-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076017-002 GABAPENTIN 300MG TABLET / ORAL 2004-04-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076017-002 GABAPENTIN 300MG TABLET / ORAL AB1 2004-04-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076017-002 GABAPENTIN 300MG TABLET / ORAL AB1 2004-04-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076017-001 GABAPENTIN 100MG TABLET / ORAL AB1 2004-04-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076017-002 GABAPENTIN 300MG TABLET / ORAL AB1 2004-04-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076017-003 GABAPENTIN 400MG TABLET / ORAL AB1 2004-04-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076017-004 GABAPENTIN 600MG TABLET / ORAL 2005-04-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076017-005 GABAPENTIN 800MG TABLET / ORAL 2005-04-29 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 125 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 21 of 21 · 402 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0093-4443 Gabapentin Gabapentin Teva Pharmaceuticals USA, Inc. ANDA Current 0093-4444 Gabapentin Gabapentin Teva Pharmaceuticals USA, Inc. ANDA Current 50436-7286 Gabapentin Gabapentin Unit Dose Services ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 8849 ORIG 2004-04-29